Spineology CE-marks OptiMesh system:
This article was originally published in Clinica
Spineology has CE-marked for sale in Europe its OptiMesh bone graft containment and reinforcement system for use in orthopaedic procedures, including those in the spine. The product can be applied through a minimally invasive approach and conforms to any defect structure, said the Stillwater, Minnesota firm. Spineology said it would use an independent network to distribute the product in Europe.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.